Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences
Inotiv (Nasdaq: NOTV) has announced its participation in two major investor conferences. Robert Leasure Jr., President and CEO, will present at the Jefferies London Global Healthcare Conference on November 19th at 1:30 p.m. GMT at the Waldorf-Hilton Hotel, London. The presentation will be available via live webcast on Inotiv's website.
Additionally, Beth Taylor, CFO, will attend the 15th Annual Craig-Hallum Alpha Select Conference on November 19th at the Sheraton NY Times Square Hotel, where she will host one-on-one meetings with investors. The company, a leading contract research organization, specializes in nonclinical and analytical drug discovery services, research models, and related products.
Inotiv (Nasdaq: NOTV) ha annunciato la sua partecipazione a due importanti conferenze per investitori. Robert Leasure Jr., Presidente e CEO, presenterà alla Jefferies London Global Healthcare Conference il 19 novembre alle 13:30 GMT presso il Waldorf-Hilton Hotel di Londra. La presentazione sarà disponibile in diretta sulla pagina web di Inotiv.
Inoltre, Beth Taylor, CFO, parteciperà alla 15th Annual Craig-Hallum Alpha Select Conference il 19 novembre presso il Sheraton NY Times Square Hotel, dove ospiterà incontri individuali con gli investitori. L'azienda, un'organizzazione di ricerca a contratto leader nel settore, è specializzata in servizi di scoperta di farmaci non clinici e analitici, modelli di ricerca e prodotti correlati.
Inotiv (Nasdaq: NOTV) ha anunciado su participación en dos importantes conferencias para inversores. Robert Leasure Jr., Presidente y CEO, presentará en la Jefferies London Global Healthcare Conference el 19 de noviembre a la 1:30 p.m. GMT en el Waldorf-Hilton Hotel, Londres. La presentación estará disponible a través de una transmisión web en vivo en el sitio web de Inotiv.
Además, Beth Taylor, CFO, asistirá a la 15th Annual Craig-Hallum Alpha Select Conference el 19 de noviembre en el Sheraton NY Times Square Hotel, donde llevará a cabo reuniones uno a uno con los inversores. La empresa, una organización líder en investigación por contrato, se especializa en servicios de descubrimiento de fármacos no clínicos y analíticos, modelos de investigación y productos relacionados.
Inotiv (Nasdaq: NOTV)는 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. Robert Leasure Jr., 사장 및 CEO는 11월 19일 오후 1시 30분 GMT에 런던의 Waldorf-Hilton Hotel에서 열리는 Jefferies London Global Healthcare Conference에서 발표를 할 예정입니다. 발표는 Inotiv 웹사이트를 통해 생중계될 예정입니다.
또한 Beth Taylor, CFO는 11월 19일에 Sheraton NY Times Square Hotel에서 개최되는 15th Annual Craig-Hallum Alpha Select Conference에 참석하여 투자자들과 일대일 회의를 주재할 것입니다. 이 회사는 비임상 및 분석 약물 발견 서비스, 연구 모델 및 관련 제품을 전문으로 하는 선도적인 계약 연구 조직입니다.
Inotiv (Nasdaq: NOTV) a annoncé sa participation à deux grandes conférences pour investisseurs. Robert Leasure Jr., Président et CEO, présentera lors de la Jefferies London Global Healthcare Conference le 19 novembre à 13h30 GMT au Waldorf-Hilton Hotel à Londres. La présentation sera disponible en direct via le site web d'Inotiv.
De plus, Beth Taylor, CFO, assistera à la 15th Annual Craig-Hallum Alpha Select Conference le 19 novembre au Sheraton NY Times Square Hotel, où elle animera des réunions individuelles avec les investisseurs. L'entreprise, un leader en organisation de recherche sous contrat, se spécialise dans les services de découverte de médicaments non cliniques et analytiques, les modèles de recherche et les produits connexes.
Inotiv (Nasdaq: NOTV) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen bekannt gegeben. Robert Leasure Jr., Präsident und CEO, wird am 19. November um 13:30 Uhr GMT auf der Jefferies London Global Healthcare Conference im Waldorf-Hilton Hotel in London präsentieren. Die Präsentation wird live über die Website von Inotiv verfügbar sein.
Zusätzlich wird Beth Taylor, CFO, an der 15th Annual Craig-Hallum Alpha Select Conference am 19. November im Sheraton NY Times Square Hotel teilnehmen, wo sie Einzelgespräche mit Investoren führen wird. Das Unternehmen, eine führende Vertragsforschungsorganisation, spezialisiert sich auf nichtklinische und analytische Arzneimittelentdeckungsdienste, Forschungsmodelle und verwandte Produkte.
- None.
- None.
WEST LAFAYETTE, Ind., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, will present at the upcoming Jefferies London Global Healthcare Conference. Beth Taylor, Chief Financial Officer, will participate at the upcoming 15th Annual Craig-Hallum Alpha Select Conference.
Conference Details
Jefferies 2024 London Global Healthcare Conference
Presenter: Robert Leasure Jr., President and Chief Executive Officer
Location: Waldorf-Hilton Hotel, London
Presentation time: Tuesday, November 19th, at 1:30 p.m. GMT (8:30 a.m. ET).
To learn more about the Jefferies event: LINK
The live webcast can be accessed in the “Investors” section of Inotiv’s website and will be archived for approximately 90 days following the event.
15th Annual Craig-Hallum Alpha Select Conference
Date: Tuesday, November 19th
Location: Sheraton NY Times Square Hotel, New York, NY
Beth Taylor is scheduled to host one-on-one meetings with investors and attendees during the conference. Investors interested in arranging one-on-one meetings should contact their Craig-Hallum conference representative.
To learn more about the Craig-Hallum event: LINK
About the Company
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to service its outstanding indebtedness and comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
| Company Contact | Investor Relations |
| Inotiv, Inc. | LifeSci Advisors |
| Beth A. Taylor, Chief Financial Officer | Bob Yedid |
| (765) 497-8381 | (516) 428-8577 |
| beth.taylor@inotiv.com | bob@lifesciadvisors.com |
FAQ
When is Inotiv (NOTV) presenting at the Jefferies London Global Healthcare Conference 2024?
Where can investors watch Inotiv's (NOTV) Jefferies conference presentation?
What investor events is Inotiv (NOTV) participating in on November 19th, 2024?
How can investors meet with Inotiv's (NOTV) CFO at the Craig-Hallum conference?
